We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ViewRay Ablative MRI System Meets Primary Goal in Pancreatic Cancer Study
ViewRay Ablative MRI System Meets Primary Goal in Pancreatic Cancer Study
Pancreatic cancer patients treated with ViewRay’s MRIdian ablative radiation technology had a one-year survival rate from diagnosis of 93.9 percent and no incidences of acute toxicity, according to study results reported at the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Antonio, Texas, Oct. 24-27.